H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes

Trends in Genetics

Volumn 32, Issue 1, 2016, Pages 29-41

  Becker, Justin S ^a   Nicetto, Dario ^a   Zaret, Kenneth S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cell identity; Development; H3K9me3; Heterochromatin; Reprogramming

Indexed keywords

HISTONE; HISTONE H3K9ME3; RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HETEROCHROMATIN;

CELL FATE; CELL LINEAGE; CELL NUCLEUS TRANSPLANTATION; DEVELOPMENTAL GENE; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE SILENCING; GENOMIC INSTABILITY; HETEROCHROMATIN; HUMAN; IN VIVO STUDY; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; ANIMAL; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE SILENCING; HETEROCHROMATIN; HISTONES; HUMANS; PLURIPOTENT STEM CELLS; TRANSCRIPTION FACTORS;

EID: 84951569125     PISSN: 01689525     EISSN: 13624555     Source Type: Journal    
DOI: 10.1016/j.tig.2015.11.001     Document Type: Review

References (143)

1. Fisher A.G., Merkenschlager M. Gene silencing, cell fate and nuclear organisation. Curr. Opin. Genet. Dev. 2002, 12:193-197.
2. Hemberger M., et al. Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal. Nat. Rev. Mol. Cell Biol. 2009, 10:526-537.
3. Meister P., et al. Locking the genome: nuclear organization and cell fate. Curr. Opin. Genet. Dev. 2011, 21:167-174.
4. Heitz E. Das Heterochromatin der Moose 1928, Bornträger.
5. Wallrath L.L., Elgin S.C. Position effect variegation in Drosophila is associated with an altered chromatin structure. Genes Dev. 1995, 9:1263-1277.
6. Frenster J.H., et al. Repressed and active chromatin isolated from interphase lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1963, 50:1026-1032.
7. Gilbert N., Allan J. Distinctive higher-order chromatin structure at mammalian centromeres. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:11949-11954.
8. Elgin S.C.R., Reuter G. Position-effect variegation, heterochromatin formation, and gene silencing in Drosophila. Cold Spring Harb. Perspect. Biol. 2013, 5:a017780.
9. Saksouk N., et al. Constitutive heterochromatin formation and transcription in mammals. Epigenetics Chromatin 2015, 8:3.
10. Trojer P., Reinberg D. Facultative heterochromatin: is there a distinctive molecular signature?. Mol. Cell 2007, 28:1-13.
11. Rea S., et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000, 406:593-599.
12. Nakayama J., et al. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 2001, 292:110-113.
13. Martens J.H.A., et al. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 2005, 24:800-812.
14. Schultz D.C., et al. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 2002, 16:919-932.
15. Tachibana M., et al. Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 2001, 276:25309-25317.
16. Tachibana M., et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002, 16:1779-1791.
17. Tachibana M., et al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 2005, 19:815-826.
18. Bannister A.J., et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001, 410:120-124.
19. Lachner M., et al. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001, 410:116-120.
20. Canzio D., et al. Chromodomain-mediated oligomerization of HP1 suggests a nucleosome-bridging mechanism for heterochromatin assembly. Mol. Cell 2011, 41:67-81.
21. Lehnertz B., et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 2003, 13:1192-1200.
22. Epsztejn-Litman S., et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat. Struct. Mol. Biol. 2008, 15:1176-1183.
23. Lee T.I., et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006, 125:301-313.
24. Boyer L.A., et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006, 441:349-353.
25. Ezhkova E., et al. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 2009, 136:1122-1135.
26. Xu C-R., et al. Dynamics of genomic H3K27me3 domains and role of EZH2 during pancreatic endocrine specification. EMBO J. 2014, 33:2157-2170.
27. Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
28. Beisel C., Paro R. Silencing chromatin: comparing modes and mechanisms. Nat. Rev. Genet. 2011, 12:123-135.
29. Hawkins R.D., et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 2010, 6:479-491.
30. Breiling A., et al. General transcription factors bind promoters repressed by Polycomb group proteins. Nature 2001, 412:651-655.
31. Dellino G.I., et al. Polycomb silencing blocks transcription initiation. Mol. Cell 2004, 13:887-893.
32. Soufi A., et al. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 2012, 151:994-1004.
33. Vogel M.J., et al. Human heterochromatin proteins form large domains containing KRAB-ZNF genes. Genome Res. 2006, 16:1493-1504.
34. O'Geen H., et al. Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs. PLoS Genet. 2007, 3:e89.
35. Zhu J., et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 2013, 152:642-654.
36. Pauler F.M., et al. H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome. Genome Res. 2009, 19:221-233.
37. Chandra T., et al. Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol. Cell 2012, 47:203-214.
38. Wen B., et al. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat. Genet. 2009, 41:246-250.
39. Filion G.J., van Steensel B. Reassessing the abundance of H3K9me2 chromatin domains in embryonic stem cells. Nat. Genet. 2010, 42:4. author reply, 5-6.
40. Lienert F., et al. Genomic prevalence of heterochromatic H3K9me2 and transcription do not discriminate pluripotent from terminally differentiated cells. PLoS Genet. 2011, 7:e1002090.
41. Liu N., et al. Recognition of H3K9 methylation by GLP is required for efficient establishment of H3K9 methylation, rapid target gene repression, and mouse viability. Genes Dev. 2015, 29:379-393.
42. Sridharan R., et al. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency. Nat. Cell Biol. 2013, 15:872-882.
43. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
44. Vierbuchen T., Wernig M. Molecular roadblocks for cellular reprogramming. Mol. Cell 2012, 47:827-838.
45. Papp B., Plath K. Epigenetics of reprogramming to induced pluripotency. Cell 2013, 152:1324-1343.
46. Soufi A., et al. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 2015, 161:555-568.
47. Iwafuchi-Doi M., Zaret K.S. Pioneer transcription factors in cell reprogramming. Genes Dev. 2014, 28:2679-2692.
48. Boyer L.A., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
49. Polo J.M., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
50. Buganim Y., et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 2012, 150:1209-1222.
51. Lister R., et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
52. Onder T.T., et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 2012, 483:598-602.
53. Shi Y., et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008, 2:525-528.
54. Huangfu D., et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 2008, 26:795-797.
55. Mali P., et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 2010, 28:713-720.
56. Liang G., et al. Butyrate promotes induced pluripotent stem cell generation. J. Biol. Chem. 2010, 285:25516-25521.
57. Mikkelsen T.S., et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
58. Hathaway N.A., et al. Dynamics and memory of heterochromatin in living cells. Cell 2012, 149:1447-1460.
59. Mansour A.A., et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature 2012, 488:409-413.
60. Pasque V., et al. Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency. J. Cell Sci. 2012, 125:6094-6104.
61. Gaspar-Maia A., et al. MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. Nat. Commun. 2013, 4:1565.
62. Pereira C.F., et al. ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. Cell Stem Cell 2010, 6:547-556.
63. Rais Y., et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 2013, 502:65-70.
64. Luo M., et al. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells. Stem Cells 2013, 31:1278-1286.
65. Ahmed K., et al. Global chromatin architecture reflects pluripotency and lineage commitment in the early mouse embryo. PLoS ONE 2010, 5:e10531.
66. Hiratani I., et al. Genome-wide dynamics of replication timing revealed by in vitro models of mouse embryogenesis. Genome Res. 2010, 20:155-169.
67. Meshorer E., Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat. Rev. Mol. Cell Biol. 2006, 7:540-546.
68. Efroni S., et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2008, 2:437-447.
69. Savić N., et al. lncRNA maturation to initiate heterochromatin formation in the nucleolus is required for exit from pluripotency in ESCs. Cell Stem Cell 2014, 15:720-734.
70. Sridharan R., et al. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009, 136:364-377.
71. Fussner E., et al. Constitutive heterochromatin reorganization during somatic cell reprogramming. EMBO J. 2011, 30:1778-1789.
72. Chen J., et al. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat. Genet. 2013, 45:34-42.
73. Jullien J., et al. Mechanisms of nuclear reprogramming by eggs and oocytes: a deterministic process?. Nat. Rev. Mol. Cell Biol. 2011, 12:453-459.
74. Matoba S., et al. Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation. Cell 2014, 159:884-895.
75. Bui H-T., et al. Histone deacetylase inhibition improves activation of ribosomal RNA genes and embryonic nucleolar reprogramming in cloned mouse embryos. Biol. Reprod. 2011, 85:1048-1056.
76. Iager A.E., et al. Trichostatin A improves histone acetylation in bovine somatic cell nuclear transfer early embryos. Cloning Stem Cells 2008, 10:371-379.
77. Blelloch R., et al. Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells 2006, 24:2007-2013.
78. Pasque V., et al. Histone variant macroH2A confers resistance to nuclear reprogramming. EMBO J. 2011, 30:2373-2387.
79. Fadloun A., et al. Mechanisms and dynamics of heterochromatin formation during mammalian development: closed paths and open questions. Curr. Top. Dev. Biol. 2013, 104:1-45.
80. Burton A., Torres-Padilla M-E. Chromatin dynamics in the regulation of cell fate allocation during early embryogenesis. Nat. Rev. Mol. Cell Biol. 2014, 15:723-734.
81. Bilodeau S., et al. SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev. 2009, 23:2484-2489.
82. Lohmann F., et al. KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation. Stem Cells 2010, 28:201-212.
83. Yeap L-S., et al. ERG-associated protein with SET domain (ESET)-Oct4 interaction regulates pluripotency and represses the trophectoderm lineage. Epigenetics Chromatin 2009, 2:12.
84. Yuan P., et al. Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev. 2009, 23:2507-2520.
85. Loh Y-H., et al. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 2007, 21:2545-2557.
86. Feldman N., et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 2006, 8:188-194.
87. Kurimoto K., et al. Quantitative dynamics of chromatin remodeling during germ cell specification from mouse embryonic stem cells. Cell Stem Cell 2015, 16:517-532.
88. Harr J.C., et al. Directed targeting of chromatin to the nuclear lamina is mediated by chromatin state and A-type lamins. J. Cell Biol. 2015, 208:33-52.
89. Dodge J.E., et al. Histone H3-K9 methyltransferase ESET is essential for early development. Mol. Cell. Biol. 2004, 24:2478-2486.
90. Peters A.H., et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001, 107:323-337.
91. Aucott R., et al. HP1-beta is required for development of the cerebral neocortex and neuromuscular junctions. J. Cell Biol. 2008, 183:597-606.
92. Allan R.S., et al. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature 2012, 487:249-253.
93. Liu J., et al. Chromatin landscape defined by repressive histone methylation during oligodendrocyte differentiation. J. Neurosci. 2015, 35:352-365.
94. Aagaard L., et al. Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31. EMBO J. 1999, 18:1923-1938.
95. Marmorstein R. Structure of SET domain proteins: a new twist on histone methylation. Trends Biochem. Sci. 2003, 28:59-62.
96. Nielsen S.J., et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 2001, 412:561-565.
97. Friedman J.R., et al. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 1996, 10:2067-2078.
98. Ryan R.F., et al. KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Krüppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. Mol. Cell. Biol. 1999, 19:4366-4378.
99. Groner A.C., et al. KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet. 2010, 6:e1000869.
100. Iyengar S., et al. Functional analysis of KAP1 genomic recruitment. Mol. Cell. Biol. 2011, 31:1833-1847.
101. Vassen L., et al. Gfi1b alters histone methylation at target gene promoters and sites of gamma-satellite containing heterochromatin. EMBO J. 2006, 25:2409-2419.
102. Yamashita K., et al. Mouse homolog of SALL1, a causative gene for Townes-Brocks syndrome, binds to A/T-rich sequences in pericentric heterochromatin via its C-terminal zinc finger domains. Genes Cells 2007, 12:171-182.
103. Bulut-Karslioglu A., et al. A transcription factor-based mechanism for mouse heterochromatin formation. Nat. Struct. Mol. Biol. 2012, 19:1023-1030.
104. Volpe T.A., et al. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 2002, 297:1833-1837.
105. Hall I.M., et al. Establishment and maintenance of a heterochromatin domain. Science 2002, 297:2232-2237.
106. Djupedal I., et al. RNA Pol II subunit Rpb7 promotes centromeric transcription and RNAi-directed chromatin silencing. Genes Dev. 2005, 19:2301-2306.
107. Kato H., et al. RNA polymerase II is required for RNAi-dependent heterochromatin assembly. Science 2005, 309:467-469.
108. Bühler M., et al. Tethering RITS to a nascent transcript initiates RNAi- and heterochromatin-dependent gene silencing. Cell 2006, 125:873-886.
109. Zhang K., et al. Roles of the Clr4 methyltransferase complex in nucleation, spreading and maintenance of heterochromatin. Nat. Struct. Mol. Biol. 2008, 15:381-388.
110. Bayne E.H., et al. Stc1: a critical link between RNAi and chromatin modification required for heterochromatin integrity. Cell 2010, 140:666-677.
111. Grewal S.I.S., Elgin S.C.R. Transcription and RNA interference in the formation of heterochromatin. Nature 2007, 447:399-406.
112. Bühler M., Moazed D. Transcription and RNAi in heterochromatic gene silencing. Nat. Struct. Mol. Biol. 2007, 14:1041-1048.
113. Bühler M., et al. RNAi-dependent and -independent RNA turnover mechanisms contribute to heterochromatic gene silencing. Cell 2007, 129:707-721.
114. Reyes-Turcu F.E., et al. Defects in RNA quality control factors reveal RNAi-independent nucleation of heterochromatin. Nat. Struct. Mol. Biol. 2011, 18:1132-1138.
115. Fukagawa T., et al. Dicer is essential for formation of the heterochromatin structure in vertebrate cells. Nat. Cell Biol. 2004, 6:784-791.
116. Kanellopoulou C., et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 2005, 19:489-501.
117. Terranova R., et al. The reorganisation of constitutive heterochromatin in differentiating muscle requires HDAC activity. Exp. Cell Res. 2005, 310:344-356.
118. Lu J., Gilbert D.M. Proliferation-dependent and cell cycle regulated transcription of mouse pericentric heterochromatin. J. Cell Biol. 2007, 179:411-421.
119. Maison C., et al. Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat. Genet. 2002, 30:329-334.
120. Muchardt C., et al. Coordinated methyl and RNA binding is required for heterochromatin localization of mammalian HP1alpha. EMBO Rep. 2002, 3:975-981.
121. Maison C., et al. SUMOylation promotes de novo targeting of HP1α to pericentric heterochromatin. Nat. Genet. 2011, 43:220-227.
122. Santenard A., et al. Heterochromatin formation in the mouse embryo requires critical residues of the histone variant H3.3. Nat. Cell Biol. 2010, 12:853-862.
123. Probst A.V., et al. A strand-specific burst in transcription of pericentric satellites is required for chromocenter formation and early mouse development. Dev. Cell 2010, 19:625-638.
124. Casanova M., et al. Heterochromatin reorganization during early mouse development requires a single-stranded noncoding transcript. Cell Rep. 2013, 4:1156-1167.
125. Millanes-Romero A., et al. Regulation of heterochromatin transcription by Snail1/LOXL2 during epithelial-to-mesenchymal transition. Mol. Cell 2013, 52:746-757.
126. Fadloun A., et al. Chromatin signatures and retrotransposon profiling in mouse embryos reveal regulation of LINE-1 by RNA. Nat. Struct. Mol. Biol. 2013, 20:332-338.
127. Chow J.C., et al. LINE-1 activity in facultative heterochromatin formation during X chromosome inactivation. Cell 2010, 141:956-969.
128. Bernstein B.E., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
129. Voigt P., et al. Asymmetrically modified nucleosomes. Cell 2012, 151:181-193.
130. Yamanaka S., Blau H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010, 465:704-712.
131. Gurdon J.B., et al. Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature 1958, 182:64-65.
132. Wilmut I., et al. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
133. Wakayama T., et al. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 1998, 394:369-374.
134. Pasque V., et al. Epigenetic factors influencing resistance to nuclear reprogramming. Trends Genet. 2011, 27:516-525.
135. Jullien J., et al. Hierarchical molecular events driven by oocyte-specific factors lead to rapid and extensive reprogramming. Mol. Cell 2014, 55:524-536.
136. Shu J., et al. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell 2013, 153:963-975.
137. Wernig M., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
138. Davis R.L., et al. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
139. Graf T., Enver T. Forcing cells to change lineages. Nature 2009, 462:587-594.
140. Ladewig J., et al. Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. Nat. Rev. Mol. Cell Biol. 2013, 14:225-236.
141. Cahan P., et al. CellNet: network biology applied to stem cell engineering. Cell 2014, 158:903-915.
142. Morris S.A., et al. Dissecting engineered cell types and enhancing cell fate conversion via CellNet. Cell 2014, 158:889-902.
143. Matsumura Y., et al. H3K4/H3K9me3 bivalent chromatin domains targeted by lineage-specific DNA methylation pauses adipocyte differentiation. Mol. Cell 2015, 60:584-596.